论文部分内容阅读
近年来用于治疗糖尿病的一项新原理,就是葡萄糖苷酶抑制物Acarbose,它在临床上已开始显示其重要意义。 作用机理:假四糖(Pseudosaccharose)对小肠粘膜细胞的葡萄糖水解酶具有高度亲和力,故可导致竞争性酶抑制,这在健康者的空肠灌注试验中已获得证实。Acarbose是一种葡萄糖苷酶抑制物,故能使碳水化物分解产生葡萄糖减少,延缓或减少在小肠中葡萄糖的吸收,因而能延缓或
A new principle that has been used to treat diabetes in recent years is the glucosidase inhibitor Acarbose, which has started to show clinical significance. Mechanism of action: Pseudosaccharose has a high affinity for glucohydrolase in small intestine mucosal cells and therefore leads to competitive enzyme inhibition, which has been demonstrated in the jejunal perfusion test in healthy individuals. Acarbose is a glucosidase inhibitor that inhibits the breakdown of carbohydrates to produce glucose, slows down or reduces the absorption of glucose in the small intestine, and thus delays or